What are the absolute and relative contraindications of sertraline?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Absolute and Relative Contraindications of Sertraline

Sertraline is absolutely contraindicated with MAOIs (including linezolid and IV methylene blue), pimozide, in patients with hypersensitivity to sertraline, and when using the oral concentrate formulation with disulfiram due to alcohol content. 1

Absolute Contraindications

Based on FDA labeling, sertraline must not be used in the following situations 1:

  • Concurrent MAOI use or within 14 days of discontinuation: This includes psychiatric MAOIs (phenelzine, isocarboxazid, moclobemide) and non-psychiatric MAOIs (linezolid, IV methylene blue, isoniazid) due to life-threatening serotonin syndrome risk 2, 1
  • Pimozide co-administration: Contraindicated due to drug interaction risk 1
  • Known hypersensitivity to sertraline or any inactive ingredients 1
  • Sertraline oral concentrate with disulfiram (Antabuse): The concentrate contains alcohol 1

Relative Contraindications and Major Precautions

While not absolute contraindications, exercise extreme caution or avoid sertraline in these situations:

Cardiac Conditions

  • History of seizure disorder: SSRIs including sertraline should be used cautiously as seizures have been observed 2
  • Cardiac conduction abnormalities: Although one case report documented sinus arrest with sertraline 3, this is rare. However, monitor patients with pre-existing cardiac conditions

Drug Interactions Requiring Caution

  • Other serotonergic drugs: Combining sertraline with SSRIs, SNRIs, TCAs, tramadol, meperidine, methadone, fentanyl, dextromethorphan, St. John's wort, L-tryptophan, or illicit drugs (MDMA, cocaine, amphetamines) increases serotonin syndrome risk. Start at low doses and titrate slowly with close monitoring in first 24-48 hours 2
  • CYP2D6 substrates: Sertraline may interact with drugs metabolized by CYP2D6, though it has less effect than fluoxetine or paroxetine 2
  • Anticoagulants and NSAIDs: Increased bleeding risk, including ecchymosis, epistaxis, petechiae, and hemorrhage when combined with aspirin or NSAIDs 2

Special Populations

  • Youth under 24 years: Black box warning for increased suicidal thinking and behavior. Close monitoring is essential, especially in first months and after dose changes 2. Recent data shows intentional self-injury is a common adverse event in patients under 18 4
  • Elderly patients (≥65 years): Increased risk of hyponatremia and falls 4. However, no dose adjustment is required based solely on age 5, 6
  • Pregnancy: Use caution and weigh risks versus benefits

Clinical Conditions

  • Bipolar disorder risk: May precipitate mania/hypomania, though this is rare. Behavioral activation is more common and typically occurs early in treatment 2
  • Bleeding disorders: Abnormal bleeding can occur, particularly with concomitant antiplatelet or anticoagulant use 2

Critical Safety Monitoring

Serotonin syndrome is the most dangerous complication, characterized by mental status changes (confusion, agitation), neuromuscular hyperactivity (tremors, clonus, hyperreflexia, rigidity), and autonomic instability (hypertension, tachycardia, diaphoresis, fever). Advanced cases can progress to seizures, arrhythmias, unconsciousness, and death 2. This requires immediate hospitalization, discontinuation of all serotonergic agents, and supportive care with continuous cardiac monitoring.

Common Pitfalls to Avoid

  • Abrupt discontinuation: Sertraline is associated with discontinuation syndrome (dizziness, nausea, paresthesias, anxiety, insomnia) though less severe than paroxetine 2. Taper gradually when stopping.
  • Overlooking drug interactions: Always review the complete medication list, including over-the-counter products, supplements, and illicit substances before prescribing 2
  • Inadequate monitoring in youth: The suicide risk in patients under 24 requires vigilant follow-up, particularly in weeks 1-4 and after dose adjustments 2, 4

References

2
Guideline

clinical practice guideline for the assessment and treatment of children and adolescents with anxiety disorders.

Journal of the American Academy of Child and Adolescent Psychiatry, 2020

3
Research

Sinus arrest due to sertraline.

Clinical cardiology, 2010

5
Research

Clinical implications of the pharmacology of sertraline.

International clinical psychopharmacology, 1991

Related Questions

What is the recommended management of all side effects of sertraline in an adult patient, including dosing, monitoring, and interventions for common adverse effects?
What is the appropriate dosing strategy for sertraline, including initiation, titration, and adjustments for elderly patients, hepatic impairment, renal impairment, pregnancy, and intolerance?
Is it normal for a patient to experience brain fog after increasing sertraline (generic) from 50 mg to 75 mg?
Does sertraline have anticholinergic activity?
What is the maximum recommended dose of sertraline for adult patients?
For an outpatient with normal hepatic and renal function, how many days should methocarbamol 750 mg orally three times daily be administered?
What are the absolute and relative contraindications of escitalopram (Lexapro)?
Can a patient with a positive stress test indicating myocardial ischemia be treated with propafenone?
For an outpatient with normal hepatic and renal function, how many days should methocarbamol 750 mg be prescribed?
In a male patient on lisinopril 40 mg, isosorbide mononitrate 30 mg, hydrochlorothiazide 25 mg, amlodipine 10 mg, a potassium‑sparing diuretic (low Calma), and carvedilol, who has impaired renal function (creatinine 2.5 mg/dL, GFR ≈28 mL/min), hyperkalemia (potassium 5.6 mmol/L), metabolic acidosis (CO₂ 15 mmol/L), and elevated BUN (64 mg/dL), what management steps should be taken?
Is there evidence that oral probiotics can alter the vaginal flora?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.